Dambkowski Carl insider trades
Dambkowski Carl has filed 38 Form 4s with the SEC that we hold, for Apogee Therapeutics, Inc. (APGE) (Chief Medical Officer) and Oruka Therapeutics, Inc. (ORKA) (Director). Across all of them we count 0 purchases worth $0 and 62 sales worth $22.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 31 sales ($18.6M). The largest single trade was a sale of 26,400 shares of Apogee Therapeutics, Inc. worth $3.5M, dated 2026-06-22. The first filing on our record is dated 2023-12-20 and the latest 2026-09-03.
Apogee Therapeutics, Inc. (APGE)
Chief Medical Officer · 33 filings · 57 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-07-03 | S, sale reported on Form 4 | 2,143 | $81.8K | 2024-07-05 |
| 2024-07-03 | S, sale reported on Form 4 | 3,852 | $143.6K | 2024-07-05 |
| 2024-08-07 | S, sale reported on Form 4 | 670 | $28.5K | 2024-08-09 |
| 2024-08-07 | S, sale reported on Form 4 | 6,523 | $264.0K | 2024-08-09 |
| 2024-08-07 | S, sale reported on Form 4 | 142 | $5.8K | 2024-08-09 |
| 2024-09-04 | S, sale reported on Form 4 | 5,878 | $279.1K | 2024-09-06 |
| 2024-09-04 | S, sale reported on Form 4 | 787 | $37.8K | 2024-09-06 |
| 2024-10-02 | S, sale reported on Form 4 | 5,740 | $322.4K | 2024-10-04 |
| 2024-10-02 | S, sale reported on Form 4 | 925 | $52.6K | 2024-10-04 |
| 2024-11-06 | S, sale reported on Form 4 | 5,326 | $313.8K | 2024-11-08 |
| 2024-11-06 | S, sale reported on Form 4 | 1,339 | $80.3K | 2024-11-08 |
| 2024-12-04 | S, sale reported on Form 4 | 6,665 | $307.1K | 2024-12-06 |
| 2024-12-11 | S, sale reported on Form 4 | 4,085 | $198.6K | 2024-12-13 |
| 2024-12-11 | S, sale reported on Form 4 | 455 | $22.8K | 2024-12-13 |
| 2025-01-02 | S, sale reported on Form 4 | 100 | $4.8K | 2025-01-03 |
| 2025-01-02 | S, sale reported on Form 4 | 1,499 | $69.6K | 2025-01-03 |
| 2025-01-02 | S, sale reported on Form 4 | 2,486 | $117.4K | 2025-01-03 |
| 2025-02-05 | S, sale reported on Form 4 | 3,520 | $143.2K | 2025-02-07 |
| 2025-03-05 | S, sale reported on Form 4 | 1,590 | $48.5K | 2025-03-07 |
| 2025-04-02 | S, sale reported on Form 4 | 889 | $33.4K | 2025-04-04 |
| 2025-04-02 | S, sale reported on Form 4 | 2,471 | $87.9K | 2025-04-04 |
| 2025-04-02 | S, sale reported on Form 4 | 500 | $18.5K | 2025-04-04 |
| 2025-05-07 | S, sale reported on Form 4 | 2,725 | $97.4K | 2025-05-09 |
| 2025-06-04 | S, sale reported on Form 4 | 2,725 | $100.7K | 2025-06-06 |
| 2025-07-02 | S, sale reported on Form 4 | 6,409 | $286.9K | 2025-07-03 |
| 2025-07-02 | S, sale reported on Form 4 | 2,935 | $133.5K | 2025-07-03 |
| 2025-07-02 | S, sale reported on Form 4 | 746 | $34.5K | 2025-07-03 |
| 2025-08-06 | S, sale reported on Form 4 | 2,725 | $103.0K | 2025-08-08 |
| 2025-09-03 | S, sale reported on Form 4 | 190 | $7.3K | 2025-09-05 |
| 2025-09-03 | S, sale reported on Form 4 | 2,535 | $95.9K | 2025-09-05 |
| 2025-10-01 | S, sale reported on Form 4 | 5,110 | $203.4K | 2025-10-03 |
| 2025-11-05 | S, sale reported on Form 4 | 2,200 | $120.6K | 2025-11-07 |
| 2025-11-05 | S, sale reported on Form 4 | 2,300 | $123.3K | 2025-11-07 |
| 2025-11-05 | S, sale reported on Form 4 | 5,607 | $311.6K | 2025-11-07 |
| 2025-11-05 | S, sale reported on Form 4 | 678 | $38.3K | 2025-11-07 |
| 2025-12-04 | S, sale reported on Form 4 | 10,900 | $817.5K | 2025-12-05 |
| 2026-01-07 | S, sale reported on Form 4 | 14,820 | $1.2M | 2026-01-09 |
| 2026-01-07 | S, sale reported on Form 4 | 826 | $65.3K | 2026-01-09 |
| 2026-01-07 | S, sale reported on Form 4 | 100 | $8.0K | 2026-01-09 |
| 2026-01-07 | S, sale reported on Form 4 | 2,954 | $227.8K | 2026-01-09 |
| 2026-02-04 | S, sale reported on Form 4 | 100 | $6.8K | 2026-02-04 |
| 2026-02-04 | S, sale reported on Form 4 | 2,481 | $161.0K | 2026-02-04 |
| 2026-02-04 | S, sale reported on Form 4 | 1,299 | $86.8K | 2026-02-04 |
| 2026-02-04 | S, sale reported on Form 4 | 1,420 | $93.5K | 2026-02-04 |
| 2026-02-04 | S, sale reported on Form 4 | 200 | $13.8K | 2026-02-04 |
| 2026-03-04 | S, sale reported on Form 4 | 2,075 | $149.4K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 3,225 | $226.8K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 200 | $14.7K | 2026-03-06 |
| 2026-04-01 | S, sale reported on Form 4 | 2,698 | $227.5K | 2026-04-03 |
| 2026-04-01 | S, sale reported on Form 4 | 2,702 | $230.6K | 2026-04-03 |
| 2026-04-01 | S, sale reported on Form 4 | 100 | $8.6K | 2026-04-03 |
| 2026-05-06 | S, sale reported on Form 4 | 1,800 | $152.3K | 2026-05-08 |
| 2026-05-06 | S, sale reported on Form 4 | 3,700 | $310.5K | 2026-05-08 |
| 2026-06-03 | S, sale reported on Form 4 | 5,500 | $432.9K | 2026-06-05 |
| 2026-06-22 | S, sale reported on Form 4 | 26,400 | $3.5M | 2026-06-24 |
| 2026-07-01 | S, sale reported on Form 4 | 5,500 | $730.1K | 2026-07-02 |
| 2026-08-05 | S, sale reported on Form 4 | 5,500 | $737.9K | 2026-08-07 |
Oruka Therapeutics, Inc. (ORKA)
Director · 5 filings · 5 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-21 | S, sale reported on Form 4 | 53,447 | $3.2M | 2026-05-22 |
| 2026-05-21 | S, sale reported on Form 4 | 13,235 | $793.7K | 2026-05-22 |
| 2026-05-21 | S, sale reported on Form 4 | 38,318 | $2.2M | 2026-05-22 |
| 2026-06-11 | S, sale reported on Form 4 | 22,417 | $1.6M | 2026-06-12 |
| 2026-06-12 | S, sale reported on Form 4 | 12,583 | $882.2K | 2026-06-12 |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1983476) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms